Immobilization, stabilization, and activation of human stem cell factor (SCF) on fragmin/protamine microparticle (F/P MP)-coated plates

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 1, 2010, Pages 32-39

  Kishimoto, Satoko ^a,b   Oonuma, Fumie ^a   Nakamura, Shingo ^a   Hattori, Hidemi ^a   Nakamura, Shin Ichiro ^a   Mori, Yasutaka ^a   Tanaka, Yoshihiro ^a   Harada, Yasuji ^b   Tagawa, Masahiro ^b   Ishihara, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Cell culture; Cytokines; Extracellular matrix; Heparin like

Indexed keywords

CELL ASSAYS; CONCENTRATION-DEPENDENT; CULTURE PLATES; CYTOKINES; ERYTHROLEUKEMIA CELLS; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HEPARIN BINDING; LOW-MOLECULAR WEIGHT HEPARINS; MICRO PARTICLES; STEM CELL FACTOR; SULFATED POLYSACCHARIDES; TF-1 CELLS;

ANIMAL CELL CULTURE; BIOCHEMISTRY; BIOLOGICAL MATERIALS; CELL CULTURE; COATINGS; POLYSACCHARIDES; STEM CELLS;

CELL IMMOBILIZATION;

BIOMATERIAL; DALTEPARIN; GLYCOSAMINOGLYCAN; POLYSACCHARIDE SULFATE; PROTAMINE; STEM CELL FACTOR; TISSUE CULTURE MEDIUM;

ARTICLE; BIOSYNTHESIS; CELL ACTIVATION; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EQUIPMENT; ERYTHROLEUKEMIA CELL; HEAT; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; PROTEIN DEGRADATION; TISSUE CULTURE PLATE;

CELL DIVISION; CELL LINE, TUMOR; DALTEPARIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HUMANS; PROTAMINES; STEM CELL FACTOR;

EID: 74749110114     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31486     Document Type: Article

References (22)

1. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ. Ex vivo expansion of umbilical cord blood stem cells for transplantation: Growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007;39:11-23.
2. Wilson A, Trumpp A. Bone-marrow haemetopoietic-stem-cell niches. Nat Rev Immunol 2006;6:93-106.
3. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006;311:1880-1885.
4. Pesce M, Farrace MG, Piacentini M, Dolci S. De Felici M. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 1993;118:1089-1094.
5. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis. Nature 1988;332:376-378.
6. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987;326:403-405.
7. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to "heparin" than anti-coagulation. Thromb Res 1994;75:1-32.
8. Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: A piece of information. FASEB J 1996;10:1270-1279.
9. Ishihara M, Ono K. Structure and function of heparin and heparan sulfate; heparinoid library and modification of FGF-activities. Trends Glycosci Glycotech 1998;10:223-233.
10. Ishihara M, Takano R, Kanda T, Hayashi K, Hara S, Kikuchi H, Yoshida K. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. J Biochem 1995;118:1255-1260.
11. Ishihara M, Kariya Y, Kikuchi H, Minamisawa T, Yoshida K. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J Biochem 1997;121:345-349.
12. Kishimoto S, Nakamura S, Hattori H, Nakamura S, Kanatani Y, Tanaka Y, Harada Y, Tagawa M, Ishihara M. Human stem cell factor (SCF) is a heparin-binding cytokine. J Biochem 2009;145:275-278.
13. Nakamura S, Kanatani Y, Kishimoto S, Nakamura S-I, Ohno C, Horio T, Hattori H, Fujita M, Tanaka Y, Kiyosawa T, Maehara T, Ishihara M. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res A. Forthcoming.
14. Humphries DE, Silbert JE. Chlorate: A reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 1988;154:365-371.
15. Farndale RW, Buttle AJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883: 173-177.
16. Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986;128:475-484.
17. Fujita M, Ishihara M, Shimizu M, Obara K, Ishizuka T, Saito Y, Yura H, Morimoto Y, Takase B, Matsui T, Kikuchi M, Maehara T. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 2004;25:699-706.
18. Nakamura S, Nambu M, Ishizuka T, Hattori H, Kanatani Y, Takase B, Kishimoto S, Amano Y, Aoki H, Kiyosawa T, Ishihara M, Maehara T. Effect of controlled release of fibro-blast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008;85:619-627.
19. Ono K, Hattori H, Takeshita S, Kurita A Ishihara M. Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 1999;9:705-711.
20. Ishihara M. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. Glycobiology 1994;4:817-824.
21. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). J Biol Chem 1993;268:23906-23914.
22. Kishimoto S, Nakamura S, Nakamura S-I, Hattori H, Oonuma F, Kanatani Y, Tanaka Y, Harada Y, Tagawa M, Maehara T, Ishihara M. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. J Control Release 2009;133:185-190.